pentoxyl has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kraal, I; Leyva, A; Pinedo, HM; Schornagel, JH; Wadman, SK | 1 |
| Bianchini, F; Cadet, J; Coudray, C; Douki, T; Ducros, V; Faure, H; Favier, A; Mousseau, M | 1 |
| Cadet, J; Faure, H; Favier, A; Guimier, C; Hida, H; Mousseau, M; Tripier, M | 1 |
3 other study(ies) available for pentoxyl and Neoplasms
| Article | Year |
|---|---|
Clinical and biochemical studies of high-dose thymidine treatment in patients with solid tumors.
Topics: Aged; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Neoplasms; Pentoxyl; Purines; Pyrimidines; Thymidine | 1984 |
5-Hydroxymethyluracil excretion, plasma TBARS and plasma antioxidant vitamins in adriamycin-treated patients.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antioxidants; DNA Damage; Doxorubicin; Female; Humans; Male; Middle Aged; Neoplasms; Pentoxyl; Thiobarbituric Acid Reactive Substances; Vitamin A; Vitamin E; Vitamins | 1996 |
Urine 8-oxo-7,8-dihydro-2-deoxyguanosine vs. 5-(hydroxymethyl) uracil as DNA oxidation marker in adriamycin-treated patients.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Antibiotics, Antineoplastic; Deoxyguanosine; DNA; Doxorubicin; Female; Humans; Male; Neoplasms; Oxidation-Reduction; Pentoxyl; Thiobarbituric Acid Reactive Substances | 1998 |